MobbleOpen in Mobble ⇢
Health · Infectious disease · published 2026-08-09 · via AJMC

Eli Lilly Invests $3.83 Billion in Vaccine Firms; FDA Panel Backs Updated COVID Shot for XFG Variant

AJMC reported on August 9 that Eli Lilly has acquired three vaccine development companies for $3.83 billion, signaling major investment in the sector. An FDA advisory panel voted to recommend updated COVID-19 vaccines targeting the XFG variant for the 2026-2027 season. These developments shape the upcoming immunization landscape.

Read the full article at AJMC →
Related stories
FDA Clears Four Updated COVID Vaccines for 2026-27 Season · Infectious disease
Medical societies issue updated vaccine guidance for flu, COVID, and RSV · Public health
SW.2 Leads COVID Variant Mix in Late August; Test Positivity Remains Low · Infectious disease
BioNTech and Genentech halt Phase 2 trial of individualized mRNA cancer shot · Cancer research
This summary is AI-generated and original to Mobble; the linked article is the authoritative source. Original headline: “Upcoming 2026-2027 Vaccine Season: Deals, Data, and an FDA Vote.” Browse more stories.